stars 1 stars 2 stars 3

Lodestone’s biosensor and reader opens the door for a broad spectrum of longitudinal in vivo assays in the tumor microenvironment. Our small-animal system and in vivo assay technology accelerates cancer research. Lodestone's products are for research use only.

Lodestone Biomedical Questions

The Lodestone Biomedical annual revenue was $3 million in 2026.

Brendan Flynn is the CEO of Lodestone Biomedical.

4 people are employed at Lodestone Biomedical.

Lodestone Biomedical is based in Lebanon, New Hampshire.

The NAICS codes for Lodestone Biomedical are [54171, 541, 541714, 54, 5417].

The SIC codes for Lodestone Biomedical are [87, 873].

Top Lodestone Biomedical Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users